tool Toolkits
Rare Disease Day 2025
27 February 2023
By IFPA
In 2022, Boehringer Ingelheim hosted a multistakeholder GPP Forum to instigate positive change for people living with generalized pustular psoriasis (GPP). these stakeholders collaborated to write a charter. The GPP Charter identifies common goals to enable people living with GPP the freedom to live the life they choose.
The Charter unites the community living with and working for GPP under a set of agreed principles to improve and change the current status quo. Through the co-creation of this charter, the views from multi-stakeholder perspectives have been considered to ensure a consistent and effective call to action for positive change across all sectors of society.
The Charter takes into consideration how GPP, a rare skin disease, can have both physical and emotional impacts on people living with the condition. Outlined below are the steps to make positive change and maintain momentum in driving GPP up the agenda.
tool Toolkits
Rare Disease Day 2025
Article Stigma, Care and Treatment
Advocating for Family Well-being in Psoriatic DiseaseArticle Stigma, Care and Treatment
Recommendations for Health Care ProfessionalsArticle Stigma, Care and Treatment
Family Well-Being in Psoriatic Disease - Caring for the CaregiverArticle Advocacy
Policy and Advocacy Officer to Global Patient OrganizationCost of treatment unbearable for patients: PA Ghana urges capture of psoriasis under NHIS
Article News
Project Rare GPP 2024: Recipients for Round 2report Advocacy, World Psoriasis Day, Comorbidities, Stigma, Living with Psoriatic Disease, About Psoriatic Disease